Alpa Garg, MD | |
736 Cambridge St, Brighton, MA 02135-2907 | |
(617) 789-2740 | |
Not Available |
Full Name | Alpa Garg |
---|---|
Gender | Female |
Speciality | Diagnostic Radiology |
Experience | 21 Years |
Location | 736 Cambridge St, Brighton, Massachusetts |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154472140 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | 221546 (Massachusetts) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Long Island Jewish Medical Center | New hyde park, NY | Hospital |
North Shore University Hospital | Manhasset, NY | Hospital |
Ns/lij Hs Southside Hospital | Bay shore, NY | Hospital |
Ns/lij Hs Huntington Hospital | Huntington, NY | Hospital |
Lenox Hill Hospital | New york, NY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
North Shore - Lij Medical Pc | 3375701568 | 5099 |
Southside Faculty Medical Affiliates University Faculty Prac | 5698175933 | 158 |
News Archive
"For more than a decade, the global conversation about development has been dominated by the Millennium Development Goals (MDGs)," Stewart Patrick, a senior fellow and director of the program on international institutions and global governance at the Council on Foreign Relations, writes in the Council's "The Internationalist" blog.
Grégoire Courtine doesn't hesitate to use the word "revolutionary" when describing the emerging field of optogenetics – a technology that uses pulses of light to control individual neural activity – and what it could mean for neuroscience. Courtine, director of the NeuroRestore research center (with neurosurgeon Jocelyne Bloch), is currently developing an optogenetic implant together with Stéphanie Lacour, who holds the Bertarelli Foundation Chair in Neuroprosthetic Technology.
Quanterix Corporation, a company digitizing biomarker analysis with the goal of advancing the science of precision health, and DestiNA Genomics Ltd, a manufacturer of patented reagents for nucleic acid detection, today announced that PLOS ONE has published a proof-of-concept single probe method for detecting microRNA biomarkers associated with liver toxicity.
Substances produced by living organisms found in nature-so-called "natural products"-have played a critical role in the development of drugs for life-threatening conditions. The anticancer agent Taxol was sourced from a plant, penicillin from a fungus, and a number of recent breakthroughs have resulted in the development and approval of anticancer drugs derived from marine sources such as coral and sponges.
Obesity is one of the most significant threats to health in the U.S. and is responsible for the development of multiple serious medical problems such as diabetes, heart disease and some forms of cancer.
› Verified 5 days ago
Entity Name | North Shore - Lij Medical Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1053688572 PECOS PAC ID: 3375701568 Enrollment ID: O20120220000262 |
News Archive
"For more than a decade, the global conversation about development has been dominated by the Millennium Development Goals (MDGs)," Stewart Patrick, a senior fellow and director of the program on international institutions and global governance at the Council on Foreign Relations, writes in the Council's "The Internationalist" blog.
Grégoire Courtine doesn't hesitate to use the word "revolutionary" when describing the emerging field of optogenetics – a technology that uses pulses of light to control individual neural activity – and what it could mean for neuroscience. Courtine, director of the NeuroRestore research center (with neurosurgeon Jocelyne Bloch), is currently developing an optogenetic implant together with Stéphanie Lacour, who holds the Bertarelli Foundation Chair in Neuroprosthetic Technology.
Quanterix Corporation, a company digitizing biomarker analysis with the goal of advancing the science of precision health, and DestiNA Genomics Ltd, a manufacturer of patented reagents for nucleic acid detection, today announced that PLOS ONE has published a proof-of-concept single probe method for detecting microRNA biomarkers associated with liver toxicity.
Substances produced by living organisms found in nature-so-called "natural products"-have played a critical role in the development of drugs for life-threatening conditions. The anticancer agent Taxol was sourced from a plant, penicillin from a fungus, and a number of recent breakthroughs have resulted in the development and approval of anticancer drugs derived from marine sources such as coral and sponges.
Obesity is one of the most significant threats to health in the U.S. and is responsible for the development of multiple serious medical problems such as diabetes, heart disease and some forms of cancer.
› Verified 5 days ago
Entity Name | Southside Faculty Medical Affiliates University Faculty Prac |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033791058 PECOS PAC ID: 5698175933 Enrollment ID: O20210608003649 |
News Archive
"For more than a decade, the global conversation about development has been dominated by the Millennium Development Goals (MDGs)," Stewart Patrick, a senior fellow and director of the program on international institutions and global governance at the Council on Foreign Relations, writes in the Council's "The Internationalist" blog.
Grégoire Courtine doesn't hesitate to use the word "revolutionary" when describing the emerging field of optogenetics – a technology that uses pulses of light to control individual neural activity – and what it could mean for neuroscience. Courtine, director of the NeuroRestore research center (with neurosurgeon Jocelyne Bloch), is currently developing an optogenetic implant together with Stéphanie Lacour, who holds the Bertarelli Foundation Chair in Neuroprosthetic Technology.
Quanterix Corporation, a company digitizing biomarker analysis with the goal of advancing the science of precision health, and DestiNA Genomics Ltd, a manufacturer of patented reagents for nucleic acid detection, today announced that PLOS ONE has published a proof-of-concept single probe method for detecting microRNA biomarkers associated with liver toxicity.
Substances produced by living organisms found in nature-so-called "natural products"-have played a critical role in the development of drugs for life-threatening conditions. The anticancer agent Taxol was sourced from a plant, penicillin from a fungus, and a number of recent breakthroughs have resulted in the development and approval of anticancer drugs derived from marine sources such as coral and sponges.
Obesity is one of the most significant threats to health in the U.S. and is responsible for the development of multiple serious medical problems such as diabetes, heart disease and some forms of cancer.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Alpa Garg, MD 736 Cambridge St, Brighton, MA 02135-2907 Ph: () - | Alpa Garg, MD 736 Cambridge St, Brighton, MA 02135-2907 Ph: (617) 789-2740 |
News Archive
"For more than a decade, the global conversation about development has been dominated by the Millennium Development Goals (MDGs)," Stewart Patrick, a senior fellow and director of the program on international institutions and global governance at the Council on Foreign Relations, writes in the Council's "The Internationalist" blog.
Grégoire Courtine doesn't hesitate to use the word "revolutionary" when describing the emerging field of optogenetics – a technology that uses pulses of light to control individual neural activity – and what it could mean for neuroscience. Courtine, director of the NeuroRestore research center (with neurosurgeon Jocelyne Bloch), is currently developing an optogenetic implant together with Stéphanie Lacour, who holds the Bertarelli Foundation Chair in Neuroprosthetic Technology.
Quanterix Corporation, a company digitizing biomarker analysis with the goal of advancing the science of precision health, and DestiNA Genomics Ltd, a manufacturer of patented reagents for nucleic acid detection, today announced that PLOS ONE has published a proof-of-concept single probe method for detecting microRNA biomarkers associated with liver toxicity.
Substances produced by living organisms found in nature-so-called "natural products"-have played a critical role in the development of drugs for life-threatening conditions. The anticancer agent Taxol was sourced from a plant, penicillin from a fungus, and a number of recent breakthroughs have resulted in the development and approval of anticancer drugs derived from marine sources such as coral and sponges.
Obesity is one of the most significant threats to health in the U.S. and is responsible for the development of multiple serious medical problems such as diabetes, heart disease and some forms of cancer.
› Verified 5 days ago
Richard Faraci, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 736 Cambridge St, Brighton, MA 02135 Phone: 617-789-3000 | |
Allison L Keel, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 736 Cambridge St, Brighton, MA 02135 Phone: 617-789-2740 | |
James Hill, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 20 Guest St Ste 225, Brighton, MA 02135 Phone: 617-738-8642 Fax: 617-202-4172 | |
Yael Vin, MD Radiology Medicare: Medicare Enrolled Practice Location: 116 North Beacon Street, Brighton, MA 02135 Phone: 617-783-5200 Fax: 617-783-5202 | |
Beth B Herrick, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 736 Cambridge St, Brighton, MA 02135 Phone: 617-789-3232 | |
Dr. Saurabh Pallod, MBBS Radiology Medicare: Not Enrolled in Medicare Practice Location: 1 Bronsdon St Apt 1b-c, Brighton, MA 02135 Phone: 508-596-6259 |